z-logo
open-access-imgOpen Access
Reduced COVID-19 Mortality With Sitagliptin Treatment? Weighing the Dissemination of Potentially Lifesaving Findings Against the Assurance of High Scientific Standards
Author(s) -
Michael A. Nauck,
Juris J. Meier
Publication year - 2020
Publication title -
diabetes care
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.636
H-Index - 363
eISSN - 1935-5548
pISSN - 0149-5992
DOI - 10.2337/dci20-0062
Subject(s) - medicine , sitagliptin , type 2 diabetes , diabetes mellitus , pneumonia , retrospective cohort study , insulin , coronary artery disease , disease , hazard ratio , intensive care medicine , endocrinology , confidence interval

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom